HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hanako Ohmatsu Selected Research

Interleukin-17 (Interleukin 17)

12/2011IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hanako Ohmatsu Research Topics

Disease

9Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
09/2015 - 12/2011
5Neoplasms (Cancer)
01/2021 - 10/2012
5Atopic Dermatitis (Atopic Eczema)
09/2014 - 05/2012
4Inflammation (Inflammations)
01/2021 - 12/2010
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021 - 08/2014
3Mycosis Fungoides
01/2017 - 03/2013
3Contact Dermatitis (Eczema, Contact)
06/2013 - 12/2010
3Pruritus (Itching)
06/2013 - 05/2012
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2021
1Erythema
01/2021
1Pigmented Nevus (Melanocytic Nevus)
10/2016
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
06/2015
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
06/2015
1Skin Diseases (Skin Disease)
09/2014
1Disease Progression
09/2014
1Infections
08/2014
1Lymphoma (Lymphomas)
01/2014
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2014
1Vitiligo
10/2013
1Hematologic Neoplasms (Hematological Malignancy)
07/2012
1Edema (Dropsy)
03/2012
1Bacterial Infections (Bacterial Infection)
12/2011
1HIV Infections (HIV Infection)
03/2011
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2011
1Hodgkin Disease (Hodgkin's Disease)
09/2010
1Hypersensitivity (Allergy)
05/2009
1Localized Scleroderma (Morphea)
11/2008

Drug/Important Bio-Agent (IBA)

3Messenger RNA (mRNA)IBA
01/2017 - 08/2014
2SteroidsIBA
01/2021 - 10/2012
2Proteins (Proteins, Gene)FDA Link
10/2016 - 09/2014
2LigandsIBA
03/2013 - 01/2011
2Irritants (Vesicants)IBA
03/2012 - 12/2010
1Methotrexate (Mexate)FDA LinkGeneric
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2017
1Complementary DNA (cDNA)IBA
10/2016
1Pancreatic Ribonuclease (Ribonuclease A)IBA
10/2016
1Ribonucleases (Ribonuclease)IBA
10/2016
1trichohyalinIBA
10/2016
1Keratins (Keratin)IBA
10/2016
1Aurora Kinase AIBA
09/2015
1ParaffinIBA
06/2015
1mogamulizumabIBA
06/2015
1CytokinesIBA
09/2014
1Adenosine Monophosphate (AMP)IBA
08/2014
1Filaggrin ProteinsIBA
08/2014
1Antimicrobial PeptidesIBA
08/2014
1S100 Proteins (S 100 Protein)IBA
08/2014
1loricrinIBA
08/2014
1Angiopoietin-2IBA
01/2014
1Angiopoietin-1IBA
01/2014
1Indicators and Reagents (Reagents)IBA
10/2013
1Nicotinamide PhosphoribosyltransferaseIBA
09/2013
1Fluorescein-5-isothiocyanate (FITC)IBA
06/2013
1DinitrofluorobenzeneIBA
06/2013
1Gastrin-Releasing PeptideIBA
06/2013
1CC ChemokinesIBA
03/2013
1Interleukin-2 Receptors (IL 2 Receptor)IBA
03/2013
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2013
1Immunoglobulin E (IgE)IBA
03/2013
1Brain-Derived Neurotrophic Factor (BDNF)IBA
03/2013
1Nerve Growth Factor (NGF)IBA
03/2013
1angiogeninIBA
07/2012
1Tacrolimus (Prograf)FDA LinkGeneric
05/2012
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2012
1EmollientsIBA
05/2012
1ChemokinesIBA
04/2012
1Member 14 Tumor Necrosis Factor ReceptorsIBA
04/2012
1Interleukin-5 (Interleukin 5)IBA
04/2012
1Interleukin-4 (Interleukin 4)IBA
04/2012
1Interleukin-2 (IL2)IBA
04/2012
1CyclinsIBA
03/2012
1AllergensIBA
03/2012
1Interleukin-17 (Interleukin 17)IBA
12/2011
1Interleukin-22 (IL-22)IBA
12/2011
1Interleukin-33IBA
03/2011
1IntegrinsIBA
12/2010
1Neutralizing AntibodiesIBA
12/2010
1AntigensIBA
12/2010
1Chemokine CCL11IBA
09/2010
1Carbamazepine (Tegretol)FDA LinkGeneric
05/2009
1anticentromere antibodyIBA
11/2008

Therapy/Procedure

1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2014
1Aftercare (After-Treatment)
10/2012
1Therapeutics
05/2012
1Intraperitoneal Injections
12/2010